Skip to content

The Metaphyseal Hip Prosthesis - Total Hip

Evaluation of the Safety and Efficiency of the Metaphyseal Hip Prosthesis - Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01501955
Enrollment
20
Registered
2011-12-30
Start date
2012-10-31
Completion date
2023-12-31
Last updated
2024-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Hip

Keywords

Osteoarthritis

Brief summary

The purpose of this study is to analyze stability, safety and efficacy of the Metaphyseal Hip Prosthesis (MHP) compared to the Stanmore hip replacement.

Detailed description

The purpose of this study is to analyze stability, safety and efficacy of the Metaphyseal Hip Prosthesis (MHP) compared to the Stanmore hip replacement at short term (1 year) and long term (10 years). Bone remodeling will be analyzed at 10 years using DEXA (Dual Energy X-Ray Absorptiometry (bone scan test)) measurements. This is a single-center prospective study with 25 patients in the study and 25 in the control group in open Randomized Clinical Trial.

Interventions

DEVICEMetaphyseal Hip Prosthesis

Metaphyseal Hip Prosthesis (MHP) hip replacement

DEVICEStanmore

Stanmore hip prosthesis

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Candidates for a total hip replacement because of arthritis of the hip * Patients with a good general condition * Patients willing and able to participate in the clinical trial with a 10 years follow up and who have signed an inform consent * Males and females * Age between 55 and 75 * Absence or little presence of osteoporotic bone (t\>-2) * ASA score 1 and 2

Exclusion criteria

* Patient with co morbidities that limit the physical abilities which may negatively influence the scores. Such co morbidities can for example be cardiac insufficiency or chronic respiratory diseases. * Severe systematic diseases such as rheumatic arthritis and SLE. * General osteoporosis (t\<-2). * Hormonal conditions such as Paget disease, which reduces the bone density. * Diseases that can negatively influence the 10 years life expectancy. * Chronic use of corticosteroids. * Extreme overweight defined as BMI above 35. * Active bacterial infection. * Mental weakness which could negatively influence the postoperative recovery and influence the ability to complete pain scores and other questionnaires. * ASA score \>2.

Design outcomes

Primary

MeasureTime frameDescription
RSA Translation X3 months, 6 months, 1 year and 2 years postoperativelyStem movement measured with RSA (radiostereometric analysis) along the x-axis in mm. RSA is a technique to accurately measure 3D movement of the prosthesis in the bone. The movement is measured with respect to the situation directly postoperative.
RSA Translation Y3 months, 6 months, 1 year and 2 years postoperativelyStem movement along the y-axis in mm. (measured with RSA)
RSA Translation Z3 months, 6 months, 1 year and 2 years postoperativelyStem movement along z-axis in mm (measured with RSA)
RSA Rotation X3 months, 6 months, 1 year and 2 years postoperativelyStem Rotation around X-axis in degrees (measured with RSA)
RSA Rotation Y3 months, 6 months, 1 year and 2 years postoperativelyStem rotation around the y-axis in degrees ( measured with RSA)
RSA Rotation Z3 months, 6 months, 1 year and 2 years postoperativelyStem rotation around the z-axis in degrees (measured with RSA)
RSA MTMP3 months, 6 months, 1 year and 2 years postoperativelyMaximum Total Point Motion (MTPM) measured with RSA. This is a mean for the total migration of the stem.

Secondary

MeasureTime frameDescription
HOOS-QoL Subscalepre-operatively, 6 weeks, 3 months, 6 months, 1,2, 3, 4, 5, 6, 7, and 10 years postoperativelyHOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
Number of Reported Device Related Complications6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, 10 years postoperativelySafety: \- Frequency of serious device related complications.
SF-12 Mental Summary Scorepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelySF-12 Score presented in Physical and Mental summary scores (range 0-100). A zero score indicates the lowest level of health and 100 indicates the highest level of health.
SF-12 Physical Summary Scorepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively12-Item Short-Form Health Survey (SF-12) presented in Physical (PS) and Mental summary (MS) scores (range 0-100). A zero score indicates the lowest level of health and 100 indicates the highest level of health.
Harris Hip Scorepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelyHarris Hip Score (HHS), a score to measure health and satisfaction after a hip prosthesis. The score has a maximum of 100 points (best possible outcome) covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points)
DEXA1 and 2 years postoperativeEfficacy: Bone density measured using the average DEXA score in each zone. For the long Stanmore the 7 Gruen zones were defined. For the short MHP stem an adjusted model with only 5 zones was used. The scan at 6 weeks is used as the baseline measurement to analyze if the bone density changes in the following years. At 1 year and 2 year follow up, percentual change is presented for both groups with respect to the 6 weeks DEXA score
HOOS-Pain Subscalepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelyHOOS (Hip disability and Osteoarthritis Outcome Score) consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
HOOS-Symptom Subscalepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelyHOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
HOOS-ADL Subscalepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelyHOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
HOOS-Sport Subscalepre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperativelyHOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Countries

Netherlands

Participant flow

Recruitment details

Participants were recruited from all patients eligible for a total hip replacement from either of the investigators at the Bravis Hospital in Roosendaal, between October 2012 and October 2013.

Pre-assignment details

Pre-operatively a DEXA scan was made to confirm eligibility.

Participants by arm

ArmCount
Stanmore
Cemented Stanmore hip stem
11
MHP Hip Stem
Cemented MHP (Metaphyseal Hip Prosthesis) hip stem
9
Total20

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event13
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicStanmoreMHP Hip StemTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
9 Participants6 Participants15 Participants
Age, Categorical
Between 18 and 65 years
2 Participants3 Participants5 Participants
Operative Side
Left
4 Participants3 Participants7 Participants
Operative Side
Right
7 Participants6 Participants13 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Netherlands
11 participants9 participants20 participants
Sex: Female, Male
Female
6 Participants5 Participants11 Participants
Sex: Female, Male
Male
5 Participants4 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 110 / 9
other
Total, other adverse events
2 / 112 / 9
serious
Total, serious adverse events
2 / 117 / 9

Outcome results

Primary

RSA MTMP

Maximum Total Point Motion (MTPM) measured with RSA. This is a mean for the total migration of the stem.

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA MTMP1 y postoperatively1.76 mmStandard Deviation 1.13
StanmoreRSA MTMP2 y postoperatively2.48 mmStandard Deviation 1.96
StanmoreRSA MTMP3 m postoperatively1.44 mmStandard Deviation 0.79
StanmoreRSA MTMP6 m postoperatively1.75 mmStandard Deviation 1.3
MHP Hip StemRSA MTMP6 m postoperatively1.34 mmStandard Deviation 0.23
MHP Hip StemRSA MTMP1 y postoperatively1.31 mmStandard Deviation 1.22
MHP Hip StemRSA MTMP3 m postoperatively0.81 mmStandard Deviation 0.29
MHP Hip StemRSA MTMP2 y postoperatively3.14 mmStandard Deviation 2.29
Primary

RSA Rotation X

Stem Rotation around X-axis in degrees (measured with RSA)

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Rotation X3 m postoperatively-0.22 mmStandard Deviation 0.68
StanmoreRSA Rotation X1 y postoperatively-0.27 mmStandard Deviation 0.48
StanmoreRSA Rotation X6 m postoperatively-0.18 mmStandard Deviation 0.74
StanmoreRSA Rotation X2 y postoperatively-0.42 mmStandard Deviation 0.92
MHP Hip StemRSA Rotation X6 m postoperatively-0.23 mmStandard Deviation 1.16
MHP Hip StemRSA Rotation X3 m postoperatively-0.18 mmStandard Deviation 0.13
MHP Hip StemRSA Rotation X2 y postoperatively-1.18 mmStandard Deviation 0.36
MHP Hip StemRSA Rotation X1 y postoperatively-0.44 mmStandard Deviation 0.37
Primary

RSA Rotation Y

Stem rotation around the y-axis in degrees ( measured with RSA)

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Rotation Y3 m postoperatively0.57 mmStandard Deviation 0.86
StanmoreRSA Rotation Y6 m postoperatively1.13 mmStandard Deviation 1.36
StanmoreRSA Rotation Y1 y postoperatively1.43 mmStandard Deviation 1.29
StanmoreRSA Rotation Y2 y postoperatively1.86 mmStandard Deviation 2
MHP Hip StemRSA Rotation Y2 y postoperatively1.50 mmStandard Deviation 0.48
MHP Hip StemRSA Rotation Y3 m postoperatively0.65 mmStandard Deviation 0.59
MHP Hip StemRSA Rotation Y1 y postoperatively0.52 mmStandard Deviation 0.23
MHP Hip StemRSA Rotation Y6 m postoperatively1.22 mmStandard Deviation 1.44
Primary

RSA Rotation Z

Stem rotation around the z-axis in degrees (measured with RSA)

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Rotation Z2 y postoperatively-0.08 mmStandard Deviation 0.57
StanmoreRSA Rotation Z3 m postoperatively-0.05 mmStandard Deviation 0.28
StanmoreRSA Rotation Z6 m postoperatively-0.01 mmStandard Deviation 0.37
StanmoreRSA Rotation Z1 y postoperatively-0.11 mmStandard Deviation 0.41
MHP Hip StemRSA Rotation Z1 y postoperatively-0.71 mmStandard Deviation 0.92
MHP Hip StemRSA Rotation Z2 y postoperatively-1.56 mmStandard Deviation 1.55
MHP Hip StemRSA Rotation Z6 m postoperatively-0.35 mmStandard Deviation 1.63
MHP Hip StemRSA Rotation Z3 m postoperatively-0.26 mmStandard Deviation 0.46
Primary

RSA Translation X

Stem movement measured with RSA (radiostereometric analysis) along the x-axis in mm. RSA is a technique to accurately measure 3D movement of the prosthesis in the bone. The movement is measured with respect to the situation directly postoperative.

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Translation X3 m postoperatively0.05 mmStandard Deviation 0.2
StanmoreRSA Translation X6 m postoperatively0.10 mmStandard Deviation 0.29
StanmoreRSA Translation X1 y postoperatively0.13 mmStandard Deviation 0.3
StanmoreRSA Translation X2 y postoperatively0.14 mmStandard Deviation 0.42
MHP Hip StemRSA Translation X2 y postoperatively0.21 mmStandard Deviation 0.6
MHP Hip StemRSA Translation X3 m postoperatively0.05 mmStandard Deviation 0.26
MHP Hip StemRSA Translation X1 y postoperatively0.08 mmStandard Deviation 0.41
MHP Hip StemRSA Translation X6 m postoperatively0.08 mmStandard Deviation 0.35
Primary

RSA Translation Y

Stem movement along the y-axis in mm. (measured with RSA)

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Translation Y3 m postoperatively-0.25 mmStandard Deviation 0.34
StanmoreRSA Translation Y6 m postoperatively-0.47 mmStandard Deviation 0.5
StanmoreRSA Translation Y1 y postoperatively-0.54 mmStandard Deviation 0.67
StanmoreRSA Translation Y2 y postoperatively-0.25 mmStandard Deviation 0.22
MHP Hip StemRSA Translation Y2 y postoperatively-0.29 mmStandard Deviation 0.43
MHP Hip StemRSA Translation Y3 m postoperatively-0.18 mmStandard Deviation 0.22
MHP Hip StemRSA Translation Y1 y postoperatively-0.25 mmStandard Deviation 0.24
MHP Hip StemRSA Translation Y6 m postoperatively-0.31 mmStandard Deviation 0.28
Primary

RSA Translation Z

Stem movement along z-axis in mm (measured with RSA)

Time frame: 3 months, 6 months, 1 year and 2 years postoperatively

Population: The population analyzed included all participants with a valid RSA baseline X-ray taken direct postoperatively and with a valid RSA X-ray at the respective time interval. Analysis was performed based on per protocol treatment.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreRSA Translation Z3 m postoperatively-0.10 mmStandard Deviation 0.36
StanmoreRSA Translation Z6 m postoperatively-0.23 mmStandard Deviation 0.45
StanmoreRSA Translation Z1 y postoperatively-0.19 mmStandard Deviation 0.23
StanmoreRSA Translation Z2 y postoperatively-0.25 mmStandard Deviation 0.22
MHP Hip StemRSA Translation Z2 y postoperatively-0.29 mmStandard Deviation 0.43
MHP Hip StemRSA Translation Z3 m postoperatively-0.08 mmStandard Deviation 0.24
MHP Hip StemRSA Translation Z1 y postoperatively-0.19 mmStandard Deviation 0.3
MHP Hip StemRSA Translation Z6 m postoperatively-0.02 mmStandard Deviation 0.19
Secondary

DEXA

Efficacy: Bone density measured using the average DEXA score in each zone. For the long Stanmore the 7 Gruen zones were defined. For the short MHP stem an adjusted model with only 5 zones was used. The scan at 6 weeks is used as the baseline measurement to analyze if the bone density changes in the following years. At 1 year and 2 year follow up, percentual change is presented for both groups with respect to the 6 weeks DEXA score

Time frame: 1 and 2 years postoperative

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Percentage of change was calculated for all participants that have paired results available (6 week and 1 year or 6 week and 2 year). For MHP stem only 5 Gruen Zones were defined, so no information available for zone 6 and 7.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreDEXAZone 7 - 1 year PO8.4 percentage of changeStandard Deviation 27.7
StanmoreDEXAZone 7 - 2 year PO8.4 percentage of changeStandard Deviation 27.7
StanmoreDEXAZone 1 - 2 year PO-4.8 percentage of changeStandard Deviation 11.4
StanmoreDEXAZone 2 - 2 year PO-2.0 percentage of changeStandard Deviation 4.5
StanmoreDEXAZone 3 - 2 year PO-3.5 percentage of changeStandard Deviation 7.2
StanmoreDEXAZone 4 - 2 year PO0.3 percentage of changeStandard Deviation 13.2
StanmoreDEXAZone 5 - 1 year PO4.4 percentage of changeStandard Deviation 6.1
StanmoreDEXAZone 5 - 2 year PO6.5 percentage of changeStandard Deviation 10.6
StanmoreDEXAZone 6 - 1 year PO2.0 percentage of changeStandard Deviation 5.9
StanmoreDEXAZone 6 - 2 year PO-1.7 percentage of changeStandard Deviation 9.4
StanmoreDEXAZone 1 - 1 year PO10.8 percentage of changeStandard Deviation 51.4
StanmoreDEXAZone 2 - 1 year PO-8.1 percentage of changeStandard Deviation 17.7
StanmoreDEXAZone 3 - 1 year PO-3.5 percentage of changeStandard Deviation 7.2
StanmoreDEXAZone 4 - 1 year PO4.3 percentage of changeStandard Deviation 5
MHP Hip StemDEXAZone 1 - 2 year PO-8.1 percentage of changeStandard Deviation 34.1
MHP Hip StemDEXAZone 5 - 1 year PO-21.3 percentage of changeStandard Deviation 28.7
MHP Hip StemDEXAZone 2 - 1 year PO-17.7 percentage of changeStandard Deviation 26.7
MHP Hip StemDEXAZone 2 - 2 year PO-6.3 percentage of changeStandard Deviation 32.3
MHP Hip StemDEXAZone 4 - 2 year PO-4.5 percentage of changeStandard Deviation 37.9
MHP Hip StemDEXAZone 3 - 1 year PO-7.4 percentage of changeStandard Deviation 15.4
MHP Hip StemDEXAZone 3 - 2 year PO-9.9 percentage of changeStandard Deviation 14.3
MHP Hip StemDEXAZone 5 - 2 year PO-19.1 percentage of changeStandard Deviation 35.9
MHP Hip StemDEXAZone 4 - 1 year PO-0.8 percentage of changeStandard Deviation 35.2
MHP Hip StemDEXAZone 1 - 1 year PO6.8 percentage of changeStandard Deviation 54.7
Secondary

Harris Hip Score

Harris Hip Score (HHS), a score to measure health and satisfaction after a hip prosthesis. The score has a maximum of 100 points (best possible outcome) covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points)

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the Harris Hip Score was performed for all fully completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHarris Hip Score1 year postoperatively95.6 Scores on a scaleStandard Deviation 5.7
StanmoreHarris Hip Score6 weeks postoperatively90.5 Scores on a scaleStandard Deviation 9.6
StanmoreHarris Hip Score2 years postoperatively94.9 Scores on a scaleStandard Deviation 1.8
StanmoreHarris Hip Score7 years postoperatively92.7 Scores on a scaleStandard Deviation 2.9
StanmoreHarris Hip Score3 years postoperatively94.9 Scores on a scaleStandard Deviation 1.8
StanmoreHarris Hip Score3 months postoperatively91.3 Scores on a scaleStandard Deviation 7.6
StanmoreHarris Hip Score4 years postoperatively92.0 Scores on a scaleStandard Deviation 8.6
StanmoreHarris Hip ScorePre-operatively50.5 Scores on a scaleStandard Deviation 12
StanmoreHarris Hip Score5 years postoperatively94.6 Scores on a scaleStandard Deviation 2.3
StanmoreHarris Hip Score6 months postoperatively94.8 Scores on a scaleStandard Deviation 6.4
StanmoreHarris Hip Score6 years postoperatively93.6 Scores on a scaleStandard Deviation 4
StanmoreHarris Hip Score10 years postoperatively87.5 Scores on a scaleStandard Deviation 14.5
MHP Hip StemHarris Hip Score6 months postoperatively82.2 Scores on a scaleStandard Deviation 18.8
MHP Hip StemHarris Hip Score10 years postoperatively96.0 Scores on a scaleStandard Deviation 0.1
MHP Hip StemHarris Hip ScorePre-operatively64.0 Scores on a scaleStandard Deviation 10.3
MHP Hip StemHarris Hip Score6 weeks postoperatively83.8 Scores on a scaleStandard Deviation 10.3
MHP Hip StemHarris Hip Score3 months postoperatively83.8 Scores on a scaleStandard Deviation 12.2
MHP Hip StemHarris Hip Score6 years postoperatively77.4 Scores on a scaleStandard Deviation 3.5
MHP Hip StemHarris Hip Score1 year postoperatively80.6 Scores on a scaleStandard Deviation 20.7
MHP Hip StemHarris Hip Score2 years postoperatively81.0 Scores on a scaleStandard Deviation 15.6
MHP Hip StemHarris Hip Score3 years postoperatively95.9 Scores on a scaleStandard Deviation 0
MHP Hip StemHarris Hip Score4 years postoperatively85.2 Scores on a scaleStandard Deviation 18.5
MHP Hip StemHarris Hip Score5 years postoperatively91.6 Scores on a scaleStandard Deviation 5.9
Secondary

HOOS-ADL Subscale

HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the HOOS Score was performed for all valid completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHOOS-ADL Subscale7 years postoperatively91.0 units on a scaleStandard Deviation 8.8
StanmoreHOOS-ADL Subscale3 months postoperatively81.4 units on a scaleStandard Deviation 15.6
StanmoreHOOS-ADL Subscale1 year postoperatively92.2 units on a scaleStandard Deviation 8.5
StanmoreHOOS-ADL Subscale5 years postoperatively88.4 units on a scaleStandard Deviation 17.2
StanmoreHOOS-ADL Subscale6 years postoperatively82.8 units on a scaleStandard Deviation 23.9
StanmoreHOOS-ADL Subscale10 years postoperatively81.6 units on a scaleStandard Deviation 21.6
StanmoreHOOS-ADL SubscalePre-operatively46.6 units on a scaleStandard Deviation 17.8
StanmoreHOOS-ADL Subscale6 weeks postoperatively76.4 units on a scaleStandard Deviation 14.5
StanmoreHOOS-ADL Subscale6 months postoperatively84.5 units on a scaleStandard Deviation 16.7
StanmoreHOOS-ADL Subscale2 years postoperatively86.2 units on a scaleStandard Deviation 14
StanmoreHOOS-ADL Subscale3 years postoperatively87.8 units on a scaleStandard Deviation 15.1
StanmoreHOOS-ADL Subscale4 years postoperatively87.7 units on a scaleStandard Deviation 15.4
MHP Hip StemHOOS-ADL Subscale3 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-ADL SubscalePre-operatively52.4 units on a scaleStandard Deviation 27.7
MHP Hip StemHOOS-ADL Subscale6 months postoperatively75.6 units on a scaleStandard Deviation 23.5
MHP Hip StemHOOS-ADL Subscale2 years postoperatively90.9 units on a scaleStandard Deviation 17.5
MHP Hip StemHOOS-ADL Subscale4 years postoperatively90.4 units on a scaleStandard Deviation 19.2
MHP Hip StemHOOS-ADL Subscale3 months postoperatively78.0 units on a scaleStandard Deviation 23.5
MHP Hip StemHOOS-ADL Subscale5 years postoperatively99.0 units on a scaleStandard Deviation 1.7
MHP Hip StemHOOS-ADL Subscale6 weeks postoperatively77.77 units on a scaleStandard Deviation 28
MHP Hip StemHOOS-ADL Subscale6 years postoperatively91.5 units on a scaleStandard Deviation 16.9
MHP Hip StemHOOS-ADL Subscale7 years postoperatively90.1 units on a scaleStandard Deviation 19.9
MHP Hip StemHOOS-ADL Subscale1 year postoperatively73.7 units on a scaleStandard Deviation 31.8
MHP Hip StemHOOS-ADL Subscale10 years postoperatively95.8 units on a scaleStandard Deviation 7.2
Secondary

HOOS-Pain Subscale

HOOS (Hip disability and Osteoarthritis Outcome Score) consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the HOOS Score was performed for all valid completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHOOS-Pain SubscalePre-operatively44.4 units on a scaleStandard Deviation 19.7
StanmoreHOOS-Pain Subscale3 months postoperatively78.6 units on a scaleStandard Deviation 15.1
StanmoreHOOS-Pain Subscale1 year postoperatively95.8 units on a scaleStandard Deviation 8
StanmoreHOOS-Pain Subscale2 years postoperatively84.8 units on a scaleStandard Deviation 18.2
StanmoreHOOS-Pain Subscale3 years postoperatively86.1 units on a scaleStandard Deviation 16.8
StanmoreHOOS-Pain Subscale5 years postoperatively87.8 units on a scaleStandard Deviation 16.7
StanmoreHOOS-Pain Subscale6 years postoperatively80.0 units on a scaleStandard Deviation 26.3
StanmoreHOOS-Pain Subscale7 years postoperatively91.1 units on a scaleStandard Deviation 7.5
StanmoreHOOS-Pain Subscale10 years postoperatively86.5 units on a scaleStandard Deviation 17.6
StanmoreHOOS-Pain Subscale6 weeks postoperatively84.2 units on a scaleStandard Deviation 11.3
StanmoreHOOS-Pain Subscale6 months postoperatively87.2 units on a scaleStandard Deviation 21.3
StanmoreHOOS-Pain Subscale4 years postoperatively88.5 units on a scaleStandard Deviation 16.6
MHP Hip StemHOOS-Pain Subscale6 months postoperatively73.9 units on a scaleStandard Deviation 24.7
MHP Hip StemHOOS-Pain SubscalePre-operatively51.7 units on a scaleStandard Deviation 27.8
MHP Hip StemHOOS-Pain Subscale6 weeks postoperatively74.7 units on a scaleStandard Deviation 23.3
MHP Hip StemHOOS-Pain Subscale6 years postoperatively89.4 units on a scaleStandard Deviation 21.3
MHP Hip StemHOOS-Pain Subscale3 months postoperatively76.1 units on a scaleStandard Deviation 21.8
MHP Hip StemHOOS-Pain Subscale1 year postoperatively78.2 units on a scaleStandard Deviation 29.5
MHP Hip StemHOOS-Pain Subscale7 years postoperatively91.3 units on a scaleStandard Deviation 17.5
MHP Hip StemHOOS-Pain Subscale2 years postoperatively84.7 units on a scaleStandard Deviation 27.6
MHP Hip StemHOOS-Pain Subscale4 years postoperatively87.5 units on a scaleStandard Deviation 25
MHP Hip StemHOOS-Pain Subscale3 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-Pain Subscale10 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-Pain Subscale5 years postoperatively98.3 units on a scaleStandard Deviation 2.9
Secondary

HOOS-QoL Subscale

HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1,2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the HOOS Score was performed for all valid completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHOOS-QoL SubscalePre-operatively34.8 units on a scaleStandard Deviation 14.6
StanmoreHOOS-QoL Subscale6 weeks postoperatively60.2 units on a scaleStandard Deviation 15.7
StanmoreHOOS-QoL Subscale6 months postoperatively74.6 units on a scaleStandard Deviation 22.8
StanmoreHOOS-QoL Subscale1 year postoperatively89.8 units on a scaleStandard Deviation 16
StanmoreHOOS-QoL Subscale3 months postoperatively59.4 units on a scaleStandard Deviation 23.4
StanmoreHOOS-QoL Subscale2 years postoperatively81.9 units on a scaleStandard Deviation 19.6
StanmoreHOOS-QoL Subscale3 years postoperatively80.6 units on a scaleStandard Deviation 28.7
StanmoreHOOS-QoL Subscale4 years postoperatively84.0 units on a scaleStandard Deviation 18
StanmoreHOOS-QoL Subscale5 years postoperatively86.8 units on a scaleStandard Deviation 18.6
StanmoreHOOS-QoL Subscale6 years postoperatively100.0 units on a scaleStandard Deviation 0
StanmoreHOOS-QoL Subscale7 years postoperatively92.9 units on a scaleStandard Deviation 14.2
StanmoreHOOS-QoL Subscale10 years postoperatively88.3 units on a scaleStandard Deviation 14.3
MHP Hip StemHOOS-QoL Subscale7 years postoperatively75.0 units on a scaleStandard Deviation 50
MHP Hip StemHOOS-QoL SubscalePre-operatively34.5 units on a scaleStandard Deviation 26.5
MHP Hip StemHOOS-QoL Subscale3 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-QoL Subscale6 years postoperatively78.1 units on a scaleStandard Deviation 43.8
MHP Hip StemHOOS-QoL Subscale6 months postoperatively59.8 units on a scaleStandard Deviation 38.7
MHP Hip StemHOOS-QoL Subscale4 years postoperatively75.0 units on a scaleStandard Deviation 50
MHP Hip StemHOOS-QoL Subscale6 weeks postoperatively60.1 units on a scaleStandard Deviation 31
MHP Hip StemHOOS-QoL Subscale10 years postoperatively93.8 units on a scaleStandard Deviation 10.8
MHP Hip StemHOOS-QoL Subscale3 months postoperatively62.5 units on a scaleStandard Deviation 40.8
MHP Hip StemHOOS-QoL Subscale1 year postoperatively68.8 units on a scaleStandard Deviation 40.3
MHP Hip StemHOOS-QoL Subscale5 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-QoL Subscale2 years postoperatively81.9 units on a scaleStandard Deviation 40.3
Secondary

HOOS-Sport Subscale

HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the HOOS Score was performed for all valid completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHOOS-Sport Subscale7 years postoperatively69.9 units on a scaleStandard Deviation 19
StanmoreHOOS-Sport Subscale4 years postoperatively71.9 units on a scaleStandard Deviation 23.9
StanmoreHOOS-Sport Subscale10 years postoperatively59.2 units on a scaleStandard Deviation 28.6
StanmoreHOOS-Sport Subscale6 weeks postoperatively56.3 units on a scaleStandard Deviation 25.3
StanmoreHOOS-Sport Subscale3 months postoperatively59.4 units on a scaleStandard Deviation 29.3
StanmoreHOOS-Sport Subscale6 months postoperatively63.1 units on a scaleStandard Deviation 28.8
StanmoreHOOS-Sport Subscale1 year postoperatively75.8 units on a scaleStandard Deviation 25.3
StanmoreHOOS-Sport Subscale2 years postoperatively68.8 units on a scaleStandard Deviation 21
StanmoreHOOS-Sport Subscale3 years postoperatively73.4 units on a scaleStandard Deviation 27.4
StanmoreHOOS-Sport Subscale5 years postoperatively71.9 units on a scaleStandard Deviation 23.9
StanmoreHOOS-Sport Subscale6 years postoperatively67.7 units on a scaleStandard Deviation 41.9
StanmoreHOOS-Sport SubscalePre-operatively27.3 units on a scaleStandard Deviation 17.5
MHP Hip StemHOOS-Sport Subscale4 years postoperatively70.8 units on a scaleStandard Deviation 50.5
MHP Hip StemHOOS-Sport SubscalePre-operatively26.6 units on a scaleStandard Deviation 21.8
MHP Hip StemHOOS-Sport Subscale1 year postoperatively41.7 units on a scaleStandard Deviation 30.8
MHP Hip StemHOOS-Sport Subscale7 years postoperatively71.9 units on a scaleStandard Deviation 39.8
MHP Hip StemHOOS-Sport Subscale6 years postoperatively62.5 units on a scaleStandard Deviation 53
MHP Hip StemHOOS-Sport Subscale10 years postoperatively100.0 units on a scale
MHP Hip StemHOOS-Sport Subscale2 years postoperatively80.0 units on a scaleStandard Deviation 30.4
MHP Hip StemHOOS-Sport Subscale6 weeks postoperatively40.3 units on a scaleStandard Deviation 30.7
MHP Hip StemHOOS-Sport Subscale5 years postoperatively100.0 units on a scale
MHP Hip StemHOOS-Sport Subscale3 months postoperatively50.0 units on a scaleStandard Deviation 33.8
MHP Hip StemHOOS-Sport Subscale3 years postoperatively100.0 units on a scaleStandard Deviation 0
MHP Hip StemHOOS-Sport Subscale6 months postoperatively48.3 units on a scaleStandard Deviation 37
Secondary

HOOS-Symptom Subscale

HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the HOOS Score was performed for all valid completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreHOOS-Symptom Subscale6 months postoperatively76.0 units on a scaleStandard Deviation 22.8
StanmoreHOOS-Symptom Subscale4 years postoperatively85.0 units on a scaleStandard Deviation 14.4
StanmoreHOOS-Symptom Subscale3 years postoperatively84.7 units on a scaleStandard Deviation 16.4
StanmoreHOOS-Symptom Subscale3 months postoperatively68.8 units on a scaleStandard Deviation 18.5
StanmoreHOOS-Symptom Subscale1 year postoperatively89.0 units on a scaleStandard Deviation 11
StanmoreHOOS-Symptom Subscale5 years postoperatively90.8 units on a scaleStandard Deviation 9.4
StanmoreHOOS-Symptom Subscale6 weeks postoperatively74.4 units on a scaleStandard Deviation 14.4
StanmoreHOOS-Symptom Subscale7 years postoperatively90.7 units on a scaleStandard Deviation 6.7
StanmoreHOOS-Symptom Subscale2 years postoperatively85.0 units on a scaleStandard Deviation 11.5
StanmoreHOOS-Symptom Subscale10 years postoperatively82.0 units on a scaleStandard Deviation 15.2
StanmoreHOOS-Symptom SubscalePre-operatively39.5 units on a scaleStandard Deviation 16.2
MHP Hip StemHOOS-Symptom Subscale10 years postoperatively81.7 units on a scaleStandard Deviation 16.1
MHP Hip StemHOOS-Symptom SubscalePre-operatively57.2 units on a scaleStandard Deviation 25
MHP Hip StemHOOS-Symptom Subscale6 weeks postoperatively63.1 units on a scaleStandard Deviation 22.7
MHP Hip StemHOOS-Symptom Subscale3 months postoperatively70.7 units on a scaleStandard Deviation 19
MHP Hip StemHOOS-Symptom Subscale6 months postoperatively75.0 units on a scaleStandard Deviation 16.8
MHP Hip StemHOOS-Symptom Subscale1 year postoperatively70.7 units on a scaleStandard Deviation 31.5
MHP Hip StemHOOS-Symptom Subscale2 years postoperatively86.7 units on a scaleStandard Deviation 14.7
MHP Hip StemHOOS-Symptom Subscale3 years postoperatively96.7 units on a scaleStandard Deviation 5.8
MHP Hip StemHOOS-Symptom Subscale4 years postoperatively82.5 units on a scaleStandard Deviation 25.3
MHP Hip StemHOOS-Symptom Subscale5 years postoperatively96.7 units on a scaleStandard Deviation 5.8
MHP Hip StemHOOS-Symptom Subscale7 years postoperatively83.8 units on a scaleStandard Deviation 20.2
Secondary

Number of Reported Device Related Complications

Safety: \- Frequency of serious device related complications.

Time frame: 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment.

ArmMeasureValue (NUMBER)
StanmoreNumber of Reported Device Related Complications1 participants
MHP Hip StemNumber of Reported Device Related Complications4 participants
Secondary

SF-12 Mental Summary Score

SF-12 Score presented in Physical and Mental summary scores (range 0-100). A zero score indicates the lowest level of health and 100 indicates the highest level of health.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the SF-12 Score was performed for all fully completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreSF-12 Mental Summary ScorePre-operatively53.7 units on a scaleStandard Deviation 7.6
StanmoreSF-12 Mental Summary Score6 weeks postoperatively56.9 units on a scaleStandard Deviation 3.7
StanmoreSF-12 Mental Summary Score3 months postoperatively59.7 units on a scaleStandard Deviation 2.8
StanmoreSF-12 Mental Summary Score6 months postoperatively59.0 units on a scaleStandard Deviation 3.5
StanmoreSF-12 Mental Summary Score1 year postoperatively56.5 units on a scaleStandard Deviation 8.1
StanmoreSF-12 Mental Summary Score2 years postoperatively57.5 units on a scaleStandard Deviation 6.3
StanmoreSF-12 Mental Summary Score3 years postoperatively58.8 units on a scaleStandard Deviation 7.9
StanmoreSF-12 Mental Summary Score4 years postoperatively60.5 units on a scaleStandard Deviation 3
StanmoreSF-12 Mental Summary Score5 years postoperatively52.7 units on a scaleStandard Deviation 7.6
StanmoreSF-12 Mental Summary Score6 years postoperatively54.1 units on a scaleStandard Deviation 10.3
StanmoreSF-12 Mental Summary Score7 years postoperatively56.8 units on a scaleStandard Deviation 2.9
StanmoreSF-12 Mental Summary Score10 years postoperatively53.6 units on a scaleStandard Deviation 10.8
MHP Hip StemSF-12 Mental Summary Score7 years postoperatively52.4 units on a scaleStandard Deviation 10.1
MHP Hip StemSF-12 Mental Summary ScorePre-operatively53.5 units on a scaleStandard Deviation 12.4
MHP Hip StemSF-12 Mental Summary Score3 years postoperatively59.8 units on a scaleStandard Deviation 1.6
MHP Hip StemSF-12 Mental Summary Score6 weeks postoperatively50.8 units on a scaleStandard Deviation 11.6
MHP Hip StemSF-12 Mental Summary Score6 years postoperatively57.2 units on a scaleStandard Deviation 5.6
MHP Hip StemSF-12 Mental Summary Score3 months postoperatively53.1 units on a scaleStandard Deviation 9.4
MHP Hip StemSF-12 Mental Summary Score4 years postoperatively57.0 units on a scaleStandard Deviation 7.1
MHP Hip StemSF-12 Mental Summary Score6 months postoperatively49.1 units on a scaleStandard Deviation 9.4
MHP Hip StemSF-12 Mental Summary Score10 years postoperatively58.9 units on a scaleStandard Deviation 0.8
MHP Hip StemSF-12 Mental Summary Score1 year postoperatively50.1 units on a scaleStandard Deviation 11.7
MHP Hip StemSF-12 Mental Summary Score5 years postoperatively57.7 units on a scaleStandard Deviation 4
MHP Hip StemSF-12 Mental Summary Score2 years postoperatively55.4 units on a scaleStandard Deviation 6.8
Secondary

SF-12 Physical Summary Score

12-Item Short-Form Health Survey (SF-12) presented in Physical (PS) and Mental summary (MS) scores (range 0-100). A zero score indicates the lowest level of health and 100 indicates the highest level of health.

Time frame: pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively

Population: The population analyzed included all participants with surgery as part of the study. Analysis was performed based on per protocol treatment. Analysis of the SF-12 Score was performed for all fully completed score forms.

ArmMeasureGroupValue (MEAN)Dispersion
StanmoreSF-12 Physical Summary Score3 years postoperatively47.3 units on a scaleStandard Deviation 9.6
StanmoreSF-12 Physical Summary Score6 weeks postoperatively44.2 units on a scaleStandard Deviation 7.3
StanmoreSF-12 Physical Summary Score4 years postoperatively45.9 units on a scaleStandard Deviation 6.7
StanmoreSF-12 Physical Summary Score6 months postoperatively46.5 units on a scaleStandard Deviation 8
StanmoreSF-12 Physical Summary Score5 years postoperatively49.2 units on a scaleStandard Deviation 7.7
StanmoreSF-12 Physical Summary ScorePre-operatively34.7 units on a scaleStandard Deviation 6.4
StanmoreSF-12 Physical Summary Score6 years postoperatively41.2 units on a scaleStandard Deviation 7.7
StanmoreSF-12 Physical Summary Score1 year postoperatively51.6 units on a scaleStandard Deviation 4.5
StanmoreSF-12 Physical Summary Score7 years postoperatively48.1 units on a scaleStandard Deviation 6.4
StanmoreSF-12 Physical Summary Score3 months postoperatively42.4 units on a scaleStandard Deviation 7.3
StanmoreSF-12 Physical Summary Score10 years postoperatively48.4 units on a scaleStandard Deviation 7.5
StanmoreSF-12 Physical Summary Score2 years postoperatively48.4 units on a scaleStandard Deviation 8.9
MHP Hip StemSF-12 Physical Summary Score10 years postoperatively48.4 units on a scaleStandard Deviation 5.2
MHP Hip StemSF-12 Physical Summary ScorePre-operatively37.3 units on a scaleStandard Deviation 8.7
MHP Hip StemSF-12 Physical Summary Score6 weeks postoperatively41.3 units on a scaleStandard Deviation 9
MHP Hip StemSF-12 Physical Summary Score3 months postoperatively43.0 units on a scaleStandard Deviation 12.5
MHP Hip StemSF-12 Physical Summary Score6 months postoperatively42.7 units on a scaleStandard Deviation 11
MHP Hip StemSF-12 Physical Summary Score1 year postoperatively48.7 units on a scaleStandard Deviation 8.2
MHP Hip StemSF-12 Physical Summary Score3 years postoperatively53.3 units on a scaleStandard Deviation 3.5
MHP Hip StemSF-12 Physical Summary Score4 years postoperatively50.6 units on a scaleStandard Deviation 7.5
MHP Hip StemSF-12 Physical Summary Score5 years postoperatively53.6 units on a scaleStandard Deviation 3.1
MHP Hip StemSF-12 Physical Summary Score6 years postoperatively49.1 units on a scaleStandard Deviation 8.8
MHP Hip StemSF-12 Physical Summary Score7 years postoperatively46.3 units on a scaleStandard Deviation 9.7
MHP Hip StemSF-12 Physical Summary Score2 years postoperatively54.4 units on a scaleStandard Deviation 3.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026